Entera Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Entera Bio and other ETFs, options, and stocks.About ENTX
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2.
CEOMiranda J. Toledano
CEOMiranda J. Toledano
Employees22
Employees22
HeadquartersJerusalem, Jerusalem
HeadquartersJerusalem, Jerusalem
Founded2009
Founded2009
Employees22
Employees22
ENTX Key Statistics
Market cap52.68M
Market cap52.68M
Price-Earnings ratio-4.53
Price-Earnings ratio-4.53
Dividend yield—
Dividend yield—
Average volume145.08K
Average volume145.08K
High today$1.15
High today$1.15
Low today$1.11
Low today$1.11
Open price$1.13
Open price$1.13
Volume34.11K
Volume34.11K
52 Week high$3.22
52 Week high$3.22
52 Week low$0.91
52 Week low$0.91
Stock Snapshot
Entera Bio(ENTX) stock is priced at $1.13, giving the company a market capitalization of 52.68M. It carries a P/E multiple of -4.53.
As of 2026-04-14, Entera Bio(ENTX) stock has fluctuated between $1.11 and $1.15. The current price stands at $1.13, placing the stock +1.8% above today's low and -1.7% off the high.
The Entera Bio(ENTX)'s current trading volume is 34.11K, compared to an average daily volume of 145.08K.
In the last year, Entera Bio(ENTX) shares hit a 52-week high of $3.22 and a 52-week low of $0.91.
In the last year, Entera Bio(ENTX) shares hit a 52-week high of $3.22 and a 52-week low of $0.91.
People also own
Based on the portfolios of people who own ENTX. This list is generated using Robinhood data, and it’s not a recommendation.